Literature DB >> 23444472

The impact of viral respiratory tract infections on long-term morbidity and mortality following lung transplantation: a retrospective cohort study using a multiplex PCR panel.

Jesper Magnusson1, Johan Westin, Lars-Magnus Andersson, Robin Brittain-Long, Gerdt C Riise.   

Abstract

BACKGROUND: The major factor affecting morbidity and mortality after lung transplantation (LTX) is bronchiolitis obliterans syndrome. Earlier studies have suggested a connection between the presence of viral agents and morbidity in this patient group, but data are somewhat conflicting. The objective of this study was to investigate the development of bronchiolitis obliterans syndrome and graft loss after LTX in relation to the presence of respiratory viruses during the first year after LTX.
METHOD: The study is a retrospective cohort study of 39 LTX recipients 11Y13 years after surgery. Patients were operated between January 1, 1998 and December 31, 2000 at Sahlgrenska University Hospital. The presence of virus in bronchoalveolar lavage (BAL) fluids from patients during the first year after surgery was analyzed retrospectively using a multiplex polymerase chain reaction test capable of detecting 15 respiratory agents. The time to BOS or graft loss was analyzed in relation to the positive findings in BAL during the first year after LTX.
RESULTS: Patients with one or more viruses detected in BAL during the first year after transplantation demonstrated a significantly faster development of BOS (P=0.005) compared with patients with no virus detected. No significant difference in graft survival was found.
CONCLUSION: Our results suggest that the long-term prognosis after LTX may be negatively affected by viral respiratory tract infections during the first year after LTX.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23444472     DOI: 10.1097/tp.0b013e318271d7f0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.

Authors:  Sachiko Seo; Angela P Campbell; Hu Xie; Jason W Chien; Wendy M Leisenring; Janet A Englund; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-05       Impact factor: 5.742

2.  Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.

Authors:  Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

3.  Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Lee Gazourian; Angela J Rogers; Ruby Ibanga; Gerald L Weinhouse; Victor Pinto-Plata; Jerome Ritz; Robert J Soiffer; Joseph H Antin; George R Washko; Rebecca M Baron; Vincent T Ho
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

4.  Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection.

Authors:  Dagmara W Lewandowska; Peter W Schreiber; Macé M Schuurmans; Bettina Ruehe; Osvaldo Zagordi; Cornelia Bayard; Michael Greiner; Fabienne D Geissberger; Riccarda Capaul; Andrea Zbinden; Jürg Böni; Christian Benden; Nicolas J Mueller; Alexandra Trkola; Michael Huber
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

Review 5.  Community-Acquired Respiratory Viruses.

Authors:  Jens Gottlieb
Journal:  Semin Respir Crit Care Med       Date:  2018-03-26       Impact factor: 3.119

6.  Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection.

Authors:  Muthukumar Gunasekaran; Sandhya Bansal; Ranjithkumar Ravichandran; Monal Sharma; Sudhir Perincheri; Francisco Rodriguez; Ramsey Hachem; Cynthia E Fisher; Ajit P Limaye; Ashraf Omar; Michael A Smith; Ross M Bremner; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2020-01-21       Impact factor: 10.247

7.  Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients: a two-center study using a multi-parameter customized respiratory Taqman® array card.

Authors:  Deborah Steensels; Marijke Reynders; Patrick Descheemaeker; Martin D Curran; Maya Hites; Isabelle Etienne; Isabel Montesinos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-20       Impact factor: 3.267

8.  Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia.

Authors:  J Karhu; T I Ala-Kokko; T Vuorinen; P Ohtonen; H Syrjälä
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

9.  Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.

Authors:  Cynthia E Fisher; Carl M Preiksaitis; Erika D Lease; Jeffrey Edelman; Katharine A Kirby; Wendy M Leisenring; Ganesh Raghu; Michael Boeckh; Ajit P Limaye
Journal:  Clin Infect Dis       Date:  2015-11-12       Impact factor: 9.079

10.  Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation.

Authors:  Jesper Magnusson; Johan Westin; Lars-Magnus Andersson; Magnus Lindh; Robin Brittain-Long; Rickard Nordén; Gerdt C Riise
Journal:  Transplant Direct       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.